ASX Ltd. Stock
ASX Ltd. gained 0.630% compared to yesterday.
The community is currently still undecided about ASX Ltd. with 2 Buy predictions and 0 Sell predictions.
As a result the target price of 36 € shows a slightly positive potential of 11.8% compared to the current price of 32.2 € for ASX Ltd..
For the coming years our community has positive and negative things to say abot the ASX Ltd. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.
Pros and Cons of ASX Ltd. in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ASX Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ASX Ltd. | 0.630% | 0.000% | -3.030% | -20.792% | 8.844% | -25.234% | -25.926% |
| Magellan Financial Group Ltd | 0.000% | -8.257% | 0.000% | 5.932% | -8.257% | -9.091% | -83.108% |
| Bendigo and Adelaide Bank Ltd | -1.560% | -2.290% | 0.787% | 0.787% | 7.563% | 4.065% | 2.400% |
| Bank of Queensland Ltd | -0.960% | -0.476% | 8.854% | 5.556% | 13.587% | -5.000% | -26.667% |
News
4 Memorable Ways to Play the HBM Market Boom
HBM memory, the critical memory component for proper AI development and application, has experienced an existential demand crisis in 2025. Analysts estimate the peak of the crisis won’t be seen
Outstanding Widespread Polymetallic Grades from Hook Lake Project
High grade polymetallic assays returned from Skyfall & Silva volcanic massive sulphide (VMS) prospects, in addition to recently announced high grade Au & Ag assays from Jaws, Quantum &
Assays Confirm up to 14.5g/ton Gold at Jaws and Significant Expansion Potential Along Strike
MHC221025News Assay Results 1 Vesper and Jaws v4 GR
Highlights
23 October 2025. Manhattan Corporation Ltd (“ASX:MHC” or the “Company” or “Manhattan”) is delighted to announce initial assay